Wyden Leads Congressional Democrats in Fifth Circuit Fight to Protect Mifepristone Access, Women’s Health Care
drugs, FDA continues to monitor the post-marketing safety data on mifepristone—data confirming that mifepristone is safe … nationwide availability and defend the drug's proven safety record. He has continued to lead congressional colleagues